Federal Register / Vol. 79, No. 248 / Monday, December 29, 2014 / Notices 78095 

42. Marlie Dulaurier, M.D., Columbus, 

Ohio, Court of Federal Claims No: 

14–1138V. 

43. Larry Thompson, Lynchburg, 

Virginia, Court of Federal Claims 

No: 14–1139V. 

44. Richard Greenslade, Ann Arbor, 

Michigan, Court of Federal Claims 

No: 14–1140V. 

45. Navid Nourani, Tempe, Arizona, 

Court of Federal Claims No: 14– 

1142V. 

46. Andrew Funk, Tempe, Arizona, 

Court of Federal Claims No: 14– 

1143V. 

47. Duke Duquette, Uxbridge, 

Massachusetts, Court of Federal 

Claims No: 14–1144V. 

48. Candace Johnson, Portland, Oregon, 

Court of Federal Claims No: 14– 

1145V. 

49. Thalia Monsha Stallworth Lewis on 

behalf of Alton Jerome Lewis, 

Deceased, Birmingham, Alabama, 

Court of Federal Claims No: 14– 

1147V. 

50. Billy Whitchurch, Dallas, Texas, 

Court of Federal Claims No: 14– 

1148V. 

51. Andrea Gasaway, Dallas, Tennessee, 

Court of Federal Claims No: 14– 

1149V. 

52. Barbara Budgake, Rahway, New 

Jersey, Court of Federal Claims No: 

14–1150V. 

53. Douglas A. Dinunzio, Charlotte, 

North Carolina, Court of Federal 

Claims No: 14–1151V. 

54. Imogene B. Fowler, Tuscaloosa, 

Alabama, Court of Federal Claims 

No: 14–1152V. 

55. Mary Daniels, Boston, 

Massachusetts, Court of Federal 

Claims No: 14–1153V. 

56. Amy Junker, Frederick, Maryland, 

Court of Federal Claims No: 14– 

1155V. 

57. Paula Pasquinelli, Carnegie, 

Pennsylvania, Court of Federal 

Claims No: 14–1156V. 

[FR Doc. 2014–30402 Filed 12–24–14; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center For Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Cell Biology 

Integrated Review Group; Nuclear and 

Cytoplasmic Structure/Function and 

Dynamics Study Section. 

Date: January 29–30, 2015. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road NW., 

Washington, DC 20015. 

Contact Person: David Balasundaram, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5189, 

MSC 7840, Bethesda, MD 20892, 301–435– 

1022, balasundaramd@csr.nih.gov. 

Name of Committee: Risk, Prevention and 

Health Behavior Integrated Review Group; 

Psychosocial Risk and Disease Prevention 

Study Section. 

Date: January 29–30, 2015. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Villa Florence Hotel, 225 Powell 

Street, San Francisco, CA 94102, 

Contact Person: Stacey FitzSimmons, 

Ph.D., MPH, Scientific Review Officer, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3114, 

MSC 7808, Bethesda, MD 20892, (301) 451– 

9956, fitzsimmonss@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Psychosocial Risk and Disease Prevention. 

Date: January 29, 2015. 

Time: 10:30 a.m. to 11:00 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Villa Florence Hotel, 225 Powell 

Street, San Francisco, CA 94102. 

Contact Person: Kristen Prentice, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3112, 

MSC 7808, Bethesda, MD 20892, (301) 496– 

0726, prenticekj@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR 13–374 

Modeling of Social Behavior. 

Date: January 29, 2015. 

Time: 12:00 p.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Jacinta Bronte-Tinkew, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3164, 

MSC 7770, Bethesda, MD 20892, (301) 806– 

0009, brontetinkewjm@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846-93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: December 19, 2014. 

Anna Snouffer, 

Deputy Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2014–30257 Filed 12–24–14; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Notice of Correction for National 

Institute of Neurological Disorders and 

Stroke, Interagency Pain Research 

Coordinating Committee Call for 

Committee Membership Nominations 

The National Institutes of Health 

(NIH) is correcting a notice previously 

published in the Federal Register on 

December 15, 2014 (79 FR 74102) and 

titled ‘‘National Institute of Neurological 

Disorders and Stroke, Interagency Pain 

Research Coordinating Committee Call 

for Committee Membership 

Nominations.’’ The notice announced 

that The Department of Health and 

Human Services (HHS) is seeking 

nominations for the Interagency Pain 

Research Coordinating Committee. 

NIH is amending the due date for 

nominations from January 5, 2015, as 

stated toward the end of the notice, to 

January 12, 2015. For further 

information about the meeting, please 

contact Linda Porter, Ph.D., porterl@ 

ninds.nih.gov. 

Dated: December 16, 2014. 

Walter J. Koroshetz, 

Acting Director, National Institute of 

Neurological Disorders and Stroke, National 

Institutes of Health. 

[FR Doc. 2014–30387 Filed 12–24–14; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

Periodically, the Substance Abuse and 

Mental Health Services Administration 

(SAMHSA) will publish a summary of 

information collection requests under 

OMB review, in compliance with the 

Paperwork Reduction Act (44 U.S.C. 

35). To request a copy of these 


tkelley on DSK3SPTVN1PROD with NOTICES